Literature DB >> 8333506

Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes.

J A Saye1, N V Ragsdale, R M Carey, M J Peach.   

Abstract

We have demonstrated that angiotensinogen is synthesized by 3T3-F442A cells and is hydrolyzed to angiotensins I and II (ANG I and II) by this model adipocyte system. This study was designed to determine whether ANG I is generated by renin or some other enzyme and where the formation of ANG I and/or II occurs in 3T3-F442A cells. Renin mRNA was not detected by Northern blot analysis of poly(A)(+)-selected RNA from cultures of fully differentiated adipocytes nor by the more sensitive polymerase chain reaction, implying that renin is not synthesized in this model adipocyte system. Hydrolysis of angiotensinogen to ANG I and II was demonstrated to be associated with the cell but not the media. Inhibitors, including EDTA, aimed at inactivating enzymes belonging to the serine, acid, or aspartyl proteases, and metalloproteases were ineffective in preventing the formation of either ANG I or II. Therefore the model adipocyte 3T3-F442A cell system forms ANG I and II in the absence of renin and angiotensin-converting enzyme. The unidentified enzymes responsible for peptide formation are associated with the cell itself.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333506     DOI: 10.1152/ajpcell.1993.264.6.C1570

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

Review 1.  Fat cell metabolism: insulin, fatty acids, and renin.

Authors:  L A Cassis
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

2.  Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice.

Authors:  Frederique Yiannikouris; Michael Karounos; Richard Charnigo; Victoria L English; Debra L Rateri; Alan Daugherty; Lisa A Cassis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

3.  Intraneuronal angiotensinergic system in rat and human dorsal root ganglia.

Authors:  Jaspal Patil; Alexander Schwab; Juerg Nussberger; Thomas Schaffner; Juan M Saavedra; Hans Imboden
Journal:  Regul Pept       Date:  2010-03-24

Review 4.  A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.

Authors:  J B Byrd; R D Brook
Journal:  J Hum Hypertens       Date:  2013-05-23       Impact factor: 3.012

5.  Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity.

Authors:  Valérie Serazin; Esther Dos Santos; Mireille Morot; Yves Giudicelli
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

6.  Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells.

Authors:  J Aubert; C Darimont; I Safonova; G Ailhaud; R Negrel
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

Review 7.  The renin angiotensin system and the metabolic syndrome.

Authors:  Annette D de Kloet; Eric G Krause; Stephen C Woods
Journal:  Physiol Behav       Date:  2010-04-08

8.  Angiotensin II-responsive element is the insulin-responsive element in the adipocyte fatty acid synthase gene: role of adipocyte determination and differentiation factor 1/sterol-regulatory-element-binding protein 1c.

Authors:  S Kim; I Dugail; M Standridge; K Claycombe; J Chun; N Moustaïd-Moussa
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

Review 9.  The intricacies of the renin-angiotensin-system in metabolic regulation.

Authors:  Erin B Bruce; Annette D de Kloet
Journal:  Physiol Behav       Date:  2016-11-22

10.  Activation of systemic, but not local, renin-angiotensin system is associated with upregulation of TNF-α during prolonged fasting in northern elephant seal pups.

Authors:  Miwa Suzuki; José Pablo Vázquez-Medina; Jose A Viscarra; José G Soñanez-Organis; Daniel E Crocker; Rudy M Ortiz
Journal:  J Exp Biol       Date:  2013-05-16       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.